Pronóstico a largo plazo de pacientes con síncope de origen desconocido y asistolia prolongada inducida mediante test de basculación

Pérez‐Paredes, Matías; Aracil, Francisco Picó; Villanueva, José; Sánchez, Rafael Florenciano; Ordóñez, Elena Expósito; Ortega, Manuel Gonzálvez; Caballero, E.v.a. González; García, M.D. Espinosa; García, Luis Iñigo; Abizanda, Juan A. Ruipérez

doi:10.1016/s0300-8932(97)73228-7

Cited by 7 publications

(1 citation statement)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite the benign course of vasovagal syncope, without mortality, there is recurrence of syncope in these patients with cardioinhibitory response from 9% to 62.5% during follow up 24 to 77 months [15, 17, 18, 23, 24]. An interesting observation is that heart rhythm during the episode of recurrence is identical to the first spontaneous syncope [25].…”

Section: Cardioinhibitory Vasovagal Syncopementioning

confidence: 99%

The Current Indication for Pacemaker in Patients with Cardioinhibitory Vasovagal Syncope

Silva

Lisboa²

2016

TOCMJ

View full text Add to dashboard Cite

The most frequent cause of syncope is vasovagal reflex. It is associated with worse quality of life, depression, fatigue and physical injury. Recurrence of vasovagal syncope is an aggravating, reaching the rate of 69%. Initial step and pharmacological treatment may not work, especially in patients with recurrent syncope without prodrome. These patients can present cardioinhibitory response with asystole. Studies were designed to analyses the effectiveness of pacemaker for prevention of syncope. In this review, nonrandomized clinical trials, open-label randomized, double-blind randomized, placebo-controlled, and studies based on tilt test or Implantable Loop Recorder findings will be discussed.

show abstract